feed,title,long_url,short_url
ðŸ’°Barrons,Reata Soars on Approval for Rare Disorder Drug. Its Pipeline Impresses Analysts.,https://barrons.com/articles/reata-pharmaceuticals-fda-approval-stock-drug-804d5df1?mod=RTA,https://da.gd/NV93
